Enhancement of clinical radioimmunotherapy for cancer and the role of cytokines.
DeNardo
S J
SJ
DeNardo
G L
GL
Richman
C M
CM
D000818:Animals; D001855:Bone Marrow Diseases / Q000209:etiology / Q000517:prevention & control*; D003131:Combined Modality Therapy; D016207:Cytokines / Q000627:therapeutic use*; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000627:therapeutic use; D006801:Humans; D007375:Interleukin-1 / Q000627:therapeutic use; D009369:Neoplasms / Q000628:therapy*; D016499:Radioimmunotherapy / Q000009:adverse effects*
D016207:Cytokines; D007375:Interleukin-1; D016178:Granulocyte-Macrophage Colony-Stimulating Factor